The Department of Health – (DOH) is the regulatory body of the Healthcare Sector at the Emirate of Abu Dhabi and ensures excellence in Healthcare for the community by monitoring the health status of the population. DOH defines the strategy for the health system, monitors and analyses the health status of the population and performance of the system.
In addition, DOH shapes the regulatory framework for the health system, inspects against regulations, enforce standards, and encourages adoption of world – class best practices and performance targets by all healthcare service providers in the Emirate.
DOH also drives programs to increase awareness and adoption of healthy living standards among the residents of the Emirate of Abu Dhabi in addition to regulating scope of services, premiums and reimbursement rates of the health system in the Emirate of Abu Dhabi. For more information visit www.haad.ae
Group 42 (G42) is a leading Artificial Intelligence and Cloud Computing company based in Abu Dhabi, uniquely positioned in the national ecosystem to develop and deploy holistic and scalable AI solutions.
G42 is founded on three core components: 1) fundamental and applied AI Research through its subsidiary the Inception Institute of Artificial Intelligence, 2) a leading Cloud Computing Platform capable of powering the largest and most demanding customers in the region 3) high-impact AI solutions optimized for a wide range of industries.
G42’s strategic direction is aligned with the vision and priorities of the UAE leadership, covering such sectors as: Smart City, Healthcare, Financial Services, Oil and Gas, Utilities, Education, Aviation, Hospitality and Tourism.
G42 has an active and extensive partnership network, connecting leading international organizations that complement its ecosystem and support our vision.
For further information on G42 visit www.g42.ai.
BGI is the world’s leading genomics solutions group, with the mission to empower the world to benefit from genomics.
Founded in 1999, BGI has continually focused on transformative genomics research and applications. From a small group of scientists participating in the Human Genome Project to becoming consistently ranked among the top scientific institutions globally, BGI continues to pioneer its omics-driven approach to solving the world’s biggest challenges in human health & wellness and in life sciences.
Beyond its research leadership, BGI also develops and manufactures breakthrough enabling technologies – both tools and infrastructure – to overcome technological limits. BGI’s services and solutions are available in more than 100 countries and regions around the world. With a fully integrated omics platform, from science to tools to solutions, BGI partners with governments and institutions in unwavering pursuit of the common goal: Omics for All.
Read more on https://en.genomics.cn
Oxford Nanopore Technologies is a UK-headquartered leading genomics technology company.
Nanopore sequencing offers DNA and RNA analysis that can deliver any read length required by the user. The system can process fragments as long as 2mb in a single read. Longer reads provide specific benefits including enhanced ability to assemble genomes, characterization of structural variation and phasing. Nanopore sequencing can also resolve methylation status directly, without the requirement for bisulfite. This can be deployed at population scale using the largest device, PromethION, which can deliver more than 7Tb of sequence data per run.